These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9447497)

  • 21. Patterns of manual dominance in patients with neuroleptic-induced movement disorders.
    Kern RS; Green MF; Satz P; Wirshing WC
    Biol Psychiatry; 1991 Sep; 30(5):483-92. PubMed ID: 1681944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 23. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S; Debsikdar V
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of anti-psychotic drugs.
    Mackay AV
    Br J Clin Pharmacol; 1981 Mar; 11(3):225-36. PubMed ID: 6111332
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
    Sadananda SK; Holla B; Viswanath B; Narasimha A; Sebastian A; Math SB; Chandrashekar CR
    J ECT; 2013 Mar; 29(1):e6-7. PubMed ID: 23422531
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA antigens in drug-induced parkinsonism.
    Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S
    Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
    Vatsek Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
    [No Abstract]   [Full Text] [Related]  

  • 30. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
    Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
    Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
    Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
    [No Abstract]   [Full Text] [Related]  

  • 33. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
    Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
    Cancro R; Davis JM; Klawans H; Tancredi L
    J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trial of L-deprenyl for the treatment of neuroleptic-induced parkinsonism.
    Rapoport A; Stein D; Schwartz M; Levin J; Stier S; Elizur A; Rabey JM
    J Neural Transm (Vienna); 1999; 106(9-10):911-8. PubMed ID: 10599872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of neuroleptic-induced parkinsonism in elderly patients with dementia.
    Sweet RA; Pollock BG; Rosen J; Mulsant BH; Altieri LP; Perel JM
    J Geriatr Psychiatry Neurol; 1994; 7(4):251-3. PubMed ID: 7826496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
    Fleischhauer J
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.